Bryan Gilburg - China

“Manufacturers using chemicals included in the list will need to submit annual usage reports to the TFDA.”

Bryan Gilburg

Managing Director

Come grow with us in the US in Thailand in China in Korea in the Philippines in Taiwan in Hong Kong

Sources and Links

The Thai FDA Updates List of Chemical Pollutants

Published on: August 25th, 2021

Manufacturers Will Need to Report Usage of Certain Chemicals

As chemical pollutants become a growing concern, The Thai FDA has released a document to have medical device regulations comply with the Stockholm Convention on Persistent Organic Pollutants. This announcement establishes rules for gathering reports on chemical substances usage, indicated in the chart below. The full announcement can be found here.

If any of these chemicals are used, the amount of usage should be reported to the Thai FDA at mdregulation@fda.moph.go.th beginning September 2021.

CAS No. 335 -67-1 Perfluorooctanoic acid (PFOA
CAS No. 3825-26-1 Ammonium Perfluorooctanoate
CAS No. 334-95-5 Sodium Perfluorooctanoate
CAS No. 2395-00-8 Potassium Perfluorooctanoate
CAS No. 335-93-3 Silver Perfluorooctanoate
CAS No. 335-66-0 Perfluorooctanoyl Fluoride
CAS No. 376-27-2 Methyl Perfluorooctanoate
CAS No. 3108-24-5 Ethyl Perfluorooctanoate

Come Grow with Us

Asia Actual has offices in Bangkok, and throughout Southeast Asia, staffed by experienced, bilingual regulatory and commercial professionals to address any questions or provide support.  Please contact us if you need regulatory support in the region.

Asia Actual is a regulatory consulting company specializing in helping manufacturers grow their sales through independent license holding, direct fulfillment, and a variety of sales channel support services.

Blog Posts

Japan's Innovative Medical Device Regulatory Pathway is called Sakigake

Innovative Medical Device Registration in Japan

In 2019, Japan's Ministry of Health, Labor and Welfare (MHLW) and Pharmaceuticals and Medical Devices Agency (PMDA) introduced a innovative device registration designation system, called Sakigake, which is meant to streamline the regulatory pathway for qualifying medical products.
Read more
PMDA Representative consulting with medical device manufacturers in Japan

Medical Device Consultation in Japan

Medical device consultation in Japan is a very involved but essential process in registering a medical device. A significant part of the regulatory process in Japan is consultation meetings with the Pharmaceuticals and Medical Devices Agency (PMDA).
Read more
Australia SaMD Transition Deadline

Australia’s SaMD Regulatory Deadline

Beginning on November 1st, 2024, Australia's Therapeutic Goods Administration will implement new rules surrounding software as a medical device (SaMD). While some SaMD will require additional regulatory requirements, other SaMD will be exempted from some, or excluded completely, from the new regulations.
Read more